Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Kirk © who wrote (2235)	11/5/2014 9:32:26 AM
From: robert b furman	1 Recommendation Recommended By Kirk © Read Replies (1) \| Respond to of 26729

I'm sitting on a double with my Amat now. Thinking about putting that money to work in brks. Both sport a 10 cent quarterly dividend and at brks's price of 10-12 vs amat's price of 20 ish - it is a better yield on more shares. That and I think that brks life sciences division is poised for growth with out any competition and sustained gross margins. Brks just announced a president of life sciences division. finance.yahoo.com They have been building a backlog and have applied their wafer automation to that of handling and storing pharma products and now biological samples. The pharma is for litigation protection and a fast growth area. The biological sample division was just purchased and is yet to be defined in revenue - but it expands an addressable market. finance.yahoo.com Lasly they are debt free and sitting on a mountain of cash - I always like that.<smile> Just my wondering thoughts. Bob